Eascra Biotech
Our novel family of Janus base nanomaterials is based on DNA nanotechnology.
12/07/2022
We talked with Steph Solis from Axios about our plans to manufacture in space. She used Axios' patented "Smart Brevity" writing model to share our plans with the world!
A Boston lab experiment in space Eascra Biotech plans to observe astronauts at the International Space Station as they develop the company's nanomaterials.
Click here to claim your Sponsored Listing.
Category
Website
Address
Boston, MA
Paul Blavin
Boston
Paul is the co-founder and CEO of Mercy Bioanalytic. He began his career in 1986 as an investment banker with Citibank and Donaldson, Lufkin & Jenrette. He then served as the Presi...
Ginkgo Biosecurity
27 Drydock Avenue
Boston, 02210
A next-generation biosecurity platform, by Ginkgo Bioworks.
Inozyme Pharma
Boston, 02210
Clinical-stage rare disease biopharmaceutical company developing novel therapeutics for treatment of abnormal mineralization diseases. We are focused on therapies to treat the rare...
Cora Care
Boston, 02109
At Cora Care, we are developing prognostic tools to help pet owners take care of their pets.
Entrada Therapeutics
Boston, 02210
Innovating to transform the treatment of devastating diseases through intracellular therapeutics.
Praxis Precision Medicines
99 High Street, 30th Floor
Boston, 02110
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, ...
NanoView Biosciences
Boston, 02135
NanoView Biosciences is focused on enabling worldwide life science researchers to better understand the biological role of extracellular vesicles, including exosomes and viral vect...
PRONOVApets
Boston
Welcome to Pronova, we are here to help you care for your pets by pioneering a new standard of care.
Alexion Pharmaceuticals
121 Seaport Boulevard
Boston, 02210
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to ...